Richard Marshall
Vorstandsvorsitzender bei Juvenescence Ltd.
Profil
Richard Marshall is currently the Chief Executive Officer at Juvenescence Ltd.
and a Director at Serina Therapeutics, Inc. He previously worked at AstraZeneca PLC as the SVP-Global Development, Respiratory & Immunology.
Dr. Marshall holds a doctorate degree from University College London.
Aktive Positionen von Richard Marshall
Unternehmen | Position | Beginn |
---|---|---|
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Vorstandsvorsitzender | 16.01.2023 |
Ehemalige bekannte Positionen von Richard Marshall
Unternehmen | Position | Ende |
---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Ausbildung von Richard Marshall
University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Finance |